Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 699

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 699
---
,109 |
| Laboratory services provided by CIBIC |     |               58,680 |     |    47,640 |
| IT Services provided by CIBIC         |     |               10,500 |     |         — |

Bioceres S.A. The Group commercializes its genetic sequencing services to Bioceres S.A.. See Note 2.4.

|                             |     | June 30, 
     2024 |     | June 30, 
     2023 |
|:----------------------------|:----|---------:|:----|---------:|
| Trade and other receivables |     |    3,501 |     |    3,536 |

Transactions with Bioceres S.A. were as follows:

|         |     | Years ended June 30, |     |       |
|         |     |                 2024 |     |  2023 |
| Revenue |     |                2,589 |     | 4,389 |

Meyerlab S.A. The Group commercializes its Heritas Dagnostics services with Meyerlab S.A. See Note 2.4.

|                   |     | June 30, 
     2024 |     | June 30, 
 2023     |
|:------------------|:----|---------:|:----|:---------|
| Trade receivables |     |    4,351 |     | —        |

Transactions with Meyerlab S.A. were as follows:

|                               |     | Years ended June 30, |     |      |
|                               |     |                 2024 |     | 2023 |
| Revenue – Heritas Diagnostics |     |               57,639 |     |    — |

F-156

Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 20.Related parties (cont.) Lease of laboratory and office space: CIBIC The Group leases space for laboratory from CIBIC. (See Note 6)

|                    |     | June 30, 
     2024 |     | June 30, 
 2023     |
|:-------------------|:----|---------:|:----|:---------|
| Right-of-use asset |     |  157,117 |     | —        |
| Lease liability    |     |  117,788 |     | —        |

INDEAR The Group terminated its lease agreement for laboratory